Antidepressant use in pregnancy: new concerns, old dilemmas

Click to increase image sizeClick to decrease image size

Acknowledgements

Christina Chambers receives grant funding for research projects not involving depression or antidepressants from Abbott Laboratories, Amgen, Apotex, Barr Laboratories, Bristol Myers Squibb, Par Laboratories, Sandoz Pharmaceuticals, Sanofi Aventis, Sanofi Pasteur and Teva Pharmaceuticals, and has served as a consultant for Cephalon Pharmaceuticals and Regeneron Pharmaceuticals. Eydie Moses-Kolko has no disclosures. Katherine Wisner receives grant funding from NIH, the Stanley Medical Research Foundation, Pfizer, the American Society for Bariatric Surgery, NYMAC and the State of Pennsylvania to study issues related to depression and/or antidepressants and to develop patient and provider educational tools. Katherine Wisner has pending grant funding from Wyeth for a study on the treatment of postpartum depression, and is a member of the GlaxoSmithKline Speakers’ Bureau.